Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large, late-stage trial among high-risk patients who had ... Show more
Story Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
Similar to This
Previous
Tragedy as 'one in a million' Northumberland mum-of-two dies after battle with melanoma
chroniclelive.co.uk/news/health/tragedy-one-million-northumberland-mum-34851616
A new cancer vaccine may keep melanoma from coming back: A personalized mRNA vaccine paired with Keytruda may help keep skin cancer from returning after surgery ...
sciencenews.org/article/cancer-vaccine-melanoma-treatment-mrna
Research success in melanoma: "The result gives hope": Cologne-based oncologist Michael Hallek discusses the development of a melanoma vaccine in an interview ...
rundschau-online.de/ratgeber/gesundheit/impfstoff-gegen-hautkrebs-das-ergebnis-macht-hoffnung-1354990
Merck and Moderna successfully test skin cancer vaccine: For the first time, an mRNA vaccine against cancer has met its objectives in a pivotal clinical trial ...
derstandard.at/story/3000000336371/merck-und-moderna-testen-erfolgreich-hautkrebs-impfstoff
Paid articlePaywall It now seems possible to vaccinate against cancer: The latest results are promising, but not yet definitive
economist.com/science-and-technology/2026/08/21/it-now-seems-possible-to-vaccinate-against-cancer
Breakthrough in Cancer Vaccine: Moderna Shares Soar to Record High: Moderna's stock rose 177 percent on Wednesday. The reason is a breakthrough involving an ...
diepresse.com/41188056/durchbruch-bei-impfung-gegen-krebs-moderna-mit-rekord-kurssprung
Key FactsModerna Shares Surge 177% After Cancer Vaccine Study
Aug 20, 2026 · Reading time: ~30 sec.
Summary created with AI assistance · Source: diepresse.com
Summary created with AI assistance · Source: diepresse.com
- Moderna shares rose 177% on Wednesday, August 19, 2026; short sellers lost five billion dollars that day.
- The final Phase 3 trial of Intismeran succeeded; combined with Keytruda, it significantly reduced recurrences after melanoma surgery.
- For each patient, Intismeran is produced as an individualized mRNA vaccine from a tumor tissue sample.
- A universal cancer vaccine is not in sight; Moderna is also testing the technology against lung and bladder cancer.
Moderna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer
scientificamerican.com/article/moderna-and-merck-announce-landmark-trial-showing-mrna-therapy-significantly-cuts-odds-of-recurrent-skin-cancer/
CNA Aug 21
CNA Explains: What we know about the Moderna, Merck breakthrough cancer vaccine: The personalised vaccine has succeeded in a final-stage melanoma trial ...
channelnewsasia.com/world/moderna-merck-mrna-cancer-vaccine-breakthrough-6333371
Moderna says skin cancer vaccine trial a success: The experimental vaccine successfully reduced the recurrence of melanoma, the company said
theweek.com/health/moderna-says-skin-cancer-vaccine-success
Your tumour, your vaccine: How Moderna and Merck mRNA therapy could change cancer treatment
firstpost.com/lifestyle/your-tumour-your-vaccine-how-moderna-and-merck-mrna-therapy-could-change-cancer-treatment-14039506.html
New hope for skin cancer: Researchers discover immune patterns that could predict treatment success
tz.de/welt/immuntherapie-bei-hautkrebs-blutzellen-als-biomarker-entdeckt-zr-94451630.html
Skin cancer vaccine slashes risk of dying from the disease - giving hope to thousands
mirror.co.uk/news/health/skin-cancer-vaccine-breakthrough-jab-37572075
Skin cancer vaccine: Moderna study meets targets - | Stock doubles: A novel skin cancer vaccine from Moderna has met its targets in a clinical trial ...
t-online.de/gesundheit/aktuelles/id_101396450/hautkrebs-impfstoff-moderna-studie-erreicht-ziele-aktie-verdoppelt-sich.html
Skin cancer breakthrough after experimental mRNA drug found to prevent disease returning
independent.co.uk/news/health/mrna-drug-skin-cancer-trial-merck-moderna-vaccine-b3035615.html
Not a 'death sentence': Immunotherapy drugs help Mount Pleasant couple survive melanoma
postandcourier.com/health/melanoma-cancer-immunotherapy-drugs/article_d086d79b-62e6-4dbd-8e9f-3bf1f4441018.html
A Skin Cancer Vaccine May Be on the Horizon: An experimental mRNA vaccine may help delay or prevent melanoma recurrence when combined with traditional treatment ...
allure.com/story/skin-cancer-personalized-mrna-vaccine-trials
Combination therapy sustains 49% melanoma reduction after 5 years: The results of a phase 2 trial, presented at ASCO 2026, suggest that a combination of a ...
medicalnewstoday.com/articles/combination-therapy-sustains-49-melanoma-reduction-after-5-years
Paid articlePaywall mRNA vaccine against cancer: Is the breakthrough imminent?: A vaccine from Moderna halves the risk of relapse in melanoma in a five-year study.
sueddeutsche.de/gesundheit/hautkrebs-mrna-impfstoff-li.3487705
help.medscape.com Sep 14 25
‘So Much More Hope’: How Immunotherapy Changed Melanoma Care: Immune checkpoint inhibitors transform the melanoma treatment landscape. The word ‘cure’ is now ...
medscape.com/viewarticle/so-much-more-hope-how-immunotherapy-changed-melanoma-care-2025a1000o62
Next